Core Viewpoint - The company, Haijia Medical, announced a share buyback program due to its stock price not reflecting its intrinsic value or business prospects, committing to repurchase shares for at least RMB 300 million [1]. Group 1: Share Buyback Announcement - On December 15, Haijia Medical disclosed its intention to buy back shares, stating that the current trading price does not reflect its intrinsic value [1]. - The company executed its first buyback on December 17, purchasing approximately 493,800 shares for about HKD 6.0098 million [1]. Group 2: Market Performance Analysis - On December 12, Haijia Medical's stock hit a year-low of HKD 11.33, indicating a downward trend away from the 5-day moving average [3]. - Since August 1, the stock has been in a downtrend, with a significant drop following a profit warning, leading to low trading volumes [3][5]. - The stock's highest price on December 12 was HKD 11.61, which was below the lower Bollinger Band of HKD 11.64, indicating an oversold condition [3]. Group 3: Trading Volume and Market Sentiment - Following the buyback announcement, trading volume increased significantly, with a notable rise in daily average volume, indicating a shift in market sentiment [5][8]. - On December 16, the stock rose by 3.27% but showed signs of selling pressure, with trading volume increasing by 152.05% compared to the previous day [5][6]. Group 4: Financial Performance and Valuation - Haijia Medical's mid-year report indicated a decline in revenue for inpatient and outpatient services, with inpatient revenue at RMB 1.22 billion (down 18.4% year-on-year) and outpatient revenue at RMB 722 million (down 11.2% year-on-year) [9]. - The company reported stable patient visits at 2.2 million, suggesting demand for its services remains unaffected despite revenue declines [9]. - The company is optimizing capital allocation, with a decrease in capital expenditures to RMB 242 million, down 28.5% year-on-year, and plans to focus on acquisitions rather than new hospital constructions [10]. Group 5: Industry Valuation Context - Haijia Medical's price-to-earnings (PE) ratio stands at 15.71, significantly lower than the industry average of 17, indicating a potential undervaluation compared to peers [11].

Core Viewpoint - The aging population is driving diverse healthcare needs, prompting medical institutions to explore enhanced service models, exemplified by Nantong Third People's Hospital's unique elderly care service approach that integrates smart technology with humanistic care [1][2] Group 1: Innovative Service Model - Nantong Third People's Hospital has developed a distinctive elderly care service model that offers comprehensive, full-cycle medical care for elderly patients [1] - The hospital has broken away from traditional treatment methods to establish a "assessment-intervention-rehabilitation-continuation" full-cycle service system [2] Group 2: Technological Integration - The hospital employs AI smart service robots for chat consultations and navigation, alongside smart beds that provide alerts for patients leaving their beds, and smart wristbands that monitor vital signs 24/7 [1] - An intelligent system for comprehensive geriatric assessment (CGA) can quickly screen over 20 indicators, allowing for personalized medical plans that include medication, rehabilitation, nutrition, and psychological support [1] Group 3: Holistic Patient Care - The hospital's care model includes a multi-disciplinary collaborative treatment system, successfully treating numerous elderly patients with complex health issues [2] - Post-discharge, patients can utilize the "Internet + Nursing Services" platform to schedule home care, ensuring seamless continuity of care [2] Group 4: Community Engagement - The hospital enriches the spiritual life of elderly patients through activities such as memory workshops and health lectures, fostering a supportive community environment [2] - Initiatives like listening communication and organizing birthday celebrations have been implemented to improve the emotional well-being of patients [2] Group 5: Commitment to Elderly Care - As an exemplary unit for elderly-friendly institutions in Jiangsu Province, Nantong Third People's Hospital aims to continuously focus on the needs of the elderly, enhancing the integration of smart technology with elderly healthcare [2]

转自：贵州日报 在清镇市妇幼保健院的专家诊室里，常能见到冯骥的身影。这份为患者守护健康的坚守，已在她的职业 生涯中延续了三十余载。 作为深耕医疗健康领域30余年的妇产科主任医师，她退休后仍返聘坚守专家门诊，以精湛医术守护群众 健康；作为执掌医院管理工作的副院长，她以专业视角统筹医疗资源，推动医疗服务提质增效；作为市 人大代表，她秉持"专业为桥、民生为根"的信念，在妇幼健康保障、人口发展促进等领域积极履职，当 好群众的"贴心人"。她就是贵阳市第十五届人大代表、清镇市市管专家、清镇市妇幼保健院原副院长冯 骥。 作为连续三届贵阳市人大代表，冯骥始终将这句誓言践行在履职的每一步。为了摸清基层民生的真实需 求，她的足迹踏遍清镇市9个乡镇街道。村卫生室的诊疗桌前、乡镇卫生院的病房里、农户家中的板凳 上，都留下了她调研走访的身影。 以医者仁心守护患者健康 2025年5月退休后，面对医院的诚意返聘，冯骥毫不犹豫地应允，还主动提出将周日纳入坐诊安排。"很 多女性平时要上班，请假看病会耽误工作，周末就诊对她们来说更方便。"一句朴实的话语，满含着冯 骥对患者的深切关怀。 这份关怀根植于家庭传承。"我的父亲是医生，他一辈子都和病人站 ...

Core Viewpoint - The inauguration of the Suzhou Hospital of the China Academy of Chinese Medical Sciences marks a significant step in enhancing traditional Chinese medicine resources in the Yangtze River Delta region [1] Group 1: Hospital Overview - The Suzhou Hospital is a collaboration between the Suzhou government and the China Academy of Chinese Medical Sciences, designed as a tertiary public traditional Chinese medicine hospital [1] - The hospital is planned to have 1,000 beds, with an initial opening of 340 beds, aiming to attract top traditional Chinese medicine talent [1] Group 2: Medical Services and Specialties - The hospital's departments cover multiple disciplines, including internal medicine (cardiology, pulmonary diseases, gastrointestinal diseases) and surgery (general surgery, vascular surgery), as well as other specialties like orthopedics, proctology, and gynecology [1] - The hospital provides comprehensive diagnosis and treatment services, addressing both common and complex medical conditions [1] Group 3: Operational Status and Achievements - Since the outpatient trial operation began on November 26 and the full opening of emergency and inpatient services on December 10, the hospital has achieved stable and orderly operations [1] - The establishment of the Qihuang Scholar Studio, featuring scholars from the China Academy of Chinese Medical Sciences, aims to enhance regional traditional Chinese medicine diagnosis and research capabilities [1] Group 4: Research and Development - The unveiling of the Suzhou branch of the National Clinical Research Center for Traditional Chinese Medicine in Cardiology within the hospital is intended to promote collaborative research and the translation of results in the field of traditional Chinese medicine for cardiovascular diseases [1]

2025年的冬至（12月21日），上百万网友等待着宁波"小洛熙"医疗纠纷的后续——两天前的晚上，"小洛熙爸爸"在社交媒体上再度发文，质 疑其5月龄女儿手术的合理性和规范性。 20日，该博文被公众人物转发，在网络上引发大量评论；同日下午5点许，宁波市卫健委工作人员回应媒体采访，称正在进行医疗事故鉴定 后续程序，尸检报告将予以考量，后续将依据医疗事故鉴定结果对涉事责任医师作出处理；当晚9点后，多家媒体报道医院就患儿部分尸检 报告发布情况说明，但一个小时后，许多人发现"宁波大学附属妇女儿童医院"微信公众号的相关文章已不见踪影。 12月21日，《每日经济新闻》记者拨打了宁波市卫健委的公开及24小时值班热线，并联系了宁波大学附属妇女儿童医院宣传科，但上述电话 均无人接听。 这次医疗事件的真相是什么？责任如何厘定？又是谁说了算？12月21日，《每日经济新闻》记者采访了医院管理人员、资深临床医生、医疗 纠纷律师和社工服务机构，还原出一条医疗事故责任认定的规范路径。 医院管理人士：我"理解"医院的沉默 2025年11月14日，宁波5月龄早产儿"小洛熙"在宁波大学附属妇女儿童医院接受心脏房间隔缺损手术后离世。 据媒体报道，"小 ...

Core Viewpoint - The establishment of the Zhejiang University School of Medicine Affiliated Shao Yifu Hospital Xinjiang Production and Construction Corps Aral Hospital as the first national regional medical center in the Corps aims to enhance healthcare services in southern Xinjiang, addressing diverse medical needs of local workers and communities [10][11]. Group 1: Medical Center Functions and Services - The national regional medical center integrates functions such as medical care, education, research, health care, rehabilitation, and emergency services, focusing on minimally invasive techniques, critical care for respiratory diseases, oncology, and emergency medical rescue [10]. - The hospital utilizes the "Internet + Medical" model to enhance service delivery, allowing patients to access quality healthcare with reduced travel [4][5]. Group 2: Collaboration and Resource Sharing - The hospital collaborates with Zhejiang University to leverage high-quality medical resources, enhancing training and talent development for the national regional medical center [7][19]. - A three-tiered medical service network has been established, integrating the national regional medical center, branch hospitals, and grassroots health facilities to improve healthcare accessibility [13]. Group 3: Technological Integration and Innovation - The hospital employs advanced technologies such as 5G, big data, and artificial intelligence to create a remote medical network, expanding its reach and improving collaborative efficiency [13]. - The introduction of medical drones for specimen transport exemplifies the hospital's commitment to smart healthcare and emergency response systems [9]. Group 4: Performance Metrics and Growth - Since its establishment, the hospital has seen significant increases in outpatient visits, inpatient admissions, and surgical procedures, with outpatient volume growing by 28.39% and surgical volume by 32.69% year-on-year [14]. - The hospital has implemented 181 new projects and filled 19 technical gaps since its opening, demonstrating its role as a regional medical leader [14]. Group 5: Talent Development and Training - The hospital has established a support mechanism involving resident experts and rotating specialists to enhance local medical staff capabilities, focusing on long-term talent cultivation [16][17]. - A total of 93 clinical experts have been dispatched to the hospital, contributing to the development of key medical disciplines and improving overall healthcare quality [17][18].

（来源：千龙网） 这并非个例。2024年，遭前妻视频举报"常年嫖娼并包养情人""通宵达旦赌博"的武汉大学人民医院胰腺 外科主任医师、武汉大学教授汤某某，在被撤职两个月后，以"科主任"身份出现在武汉市第六医院的挂 号系统中，也曾引发关注。 尽管医院称其录用流程"合规"，舆论却仍然紧盯不放，这也说明公众对于医德不会置之不理。现如今， 同样的舆论压力之下，铜仁这家医院表示祖某某"不来了"，短短一天，该坐诊消息便经历了发布、发 酵、撤回全过程。 事情过了一个多月，祖某某就开始公开出诊了，这多少让人有些意外。毕竟，如果处理结果尚未公布， 按道理他就仍处在调查阶段，相关责任与边界并未厘清。这当中是否有权力滥用、利益输送，本身也还 需要调查厘清。 在此情况下，医院贸然以"全国知名专家"的身份对外宣传其坐诊安排，本身就极易引发误解，这样 的"擦边"行为似乎在有意淡化对其调查的严肃性，甚至给人以"风波已过、照常出诊"的错误信号。 在网络上也有声音认为，祖某某生活作风问题只是"私德"，与其医疗专业水平并无关系。 但医疗领域是特殊的。这是因为医生直接介入他人的身体、尊严与生命安全，所以医疗行业对从业者的 要求，从来不只是技术是否精 ...

Investment Rating - The report maintains a "Buy" rating for the medical services industry [6][9] Core Insights - The medical services sector has shown resilience, with a slight increase in valuation despite overall market corrections, highlighting its value proposition [6][9] - The recent passage of the U.S. 2026 National Defense Authorization Act (NDAA) is expected to ease the immediate impact on the domestic biopharmaceutical industry, particularly for companies like WuXi AppTec and WuXi Biologics [5][61] Summary by Sections Industry Performance - The pharmaceutical and biological sector declined by 0.14%, ranking 22nd among 31 primary industries [1][11] - The medical services sub-sector index closed at 6344.37 points, up by 0.55% [22][23] Company Performance - Top-performing companies in the medical services sector include: - Meinian Health (+24.1%) - Baihua Pharmaceutical (+8.8%) - Dian Diagnostics (+8.1%) [2][27] - Underperforming companies include: - Nanhua Biological (-6.5%) - Medisyn (-5.2%) [2][27] Valuation Metrics - The current Price-to-Earnings (PE) ratio for the medical services sector is 32.03X, with a Price-to-Book (PB) ratio of 3.23X [3][29] - The PE ratio has increased by 0.29X from the previous week, while the PB ratio has risen by 0.03X [29] Investment Recommendations - The report suggests focusing on high-growth areas such as ADC CDMO and the peptide CDMO in the weight-loss drug supply chain, with specific companies like WuXi AppTec and Haoyuan Pharmaceutical highlighted [9][62] - It also recommends monitoring third-party testing laboratories and consumer healthcare sectors, particularly in ophthalmology and dentistry, with companies like Aier Eye Hospital and Dian Diagnostics [9][62]

Core Viewpoint - The article discusses the recent incident involving a child who died after heart surgery at Ningbo Women's and Children's Hospital, highlighting discrepancies in the reported size of the heart defect and the implications for medical intervention [3][4]. Group 1: Incident Overview - The autopsy report indicated that the size of the atrial septal defect (ASD) was 1.0cm x 0.9cm, contrary to the family's claim of 0.3cm, suggesting significant implications for the child's growth and development [3]. - Following the child's death, multiple hospital officials, including the chief surgeon, faced disciplinary actions, although the technical assessment of the medical incident has not yet been released [3][4]. Group 2: Medical Context - Atrial septal defects are common in premature infants, with larger defects typically requiring intervention. The standard for surgical intervention in children is flexible, often depending on the size of the defect and the child's age [4]. - Experts indicate that small atrial septal defects may self-resolve, and diagnosis before six months may not be reliable. Surgical intervention is generally recommended before school age to prevent long-term developmental impacts [4]. Group 3: Treatment Options - Treatment for atrial septal defects can be performed via minimally invasive techniques or open-heart surgery, with the choice depending on the defect's characteristics and the patient's condition [5]. - The materials used for surgical repair include autologous pericardium or specially processed bovine pericardium, while interventional procedures utilize occluders made from nickel-titanium alloy [5]. Group 4: Epidemiological Data - Recent epidemiological studies indicate that the incidence of congenital heart disease in China ranges from 8 to 10 per 1,000 live births, with atrial septal defects accounting for approximately 10% to 15% of these cases [6]. - Based on these statistics, the birth prevalence of atrial septal defects is estimated to be between 0.8 and 1.5 per 1,000 live births [6].

AI肿瘤全周期健康管理生态平台启动） 本报记者 刘钊 12月19日，盈康生命科技股份有限公司（以下简称"盈康生命"）在北京举办"AI肿瘤全周期健康管理发 展论坛"。论坛聚焦人工智能赋能肿瘤防治体系变革，来自政策研究、临床医学、科技企业及产业投资 等多领域的专家学者与生态伙伴，共同探讨AI驱动下肿瘤防控新模式的构建。 盈康生命董事兼总经理马安捷称，"公司使命将变成以科技为驱动，为用户提供全场景、全周期的整合 式的健康管理服务。我们将围绕着肿瘤、血液、居家等场景，在医疗服务和医疗器械双轮驱动的基础 上，以科技创新为底座，构建一个AI驱动下的健康解决方案平台"。有业内人士表示，此举将为公司发 展注入全新动能，且可能颠覆传统医疗服务行业生态。 （盈康生命 与传统的互联网医院模式和线下医院的数字化升级不同，盈康生命肿瘤全周期健康管理智能体真正实现 了线上线下的融合，形成了肿瘤全周期健康管理的新业态。 据了解，盈康生命旗下医院每年服务近20万肿瘤患者。目前，我国肿瘤防治事业面临的系统性挑战，同 时叠加人口老龄化趋势，社会对肿瘤长期、连续照护的需求日益迫切。因而，突破传统以医院为中心 的"片段化"诊疗模式，构建覆盖预防、诊 ...